CLINICAL_TRIALS
research
· 2026-02-05
Clinical Trial Update: Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes [NA]
Summary
A registered clinical trial is evaluating the probiotic Weizmannia coagulans JBI-YZ6.3 for effects on gut health and the fecal microbiome in people with gastroi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lindenwood University | Conditions: Gastrointestinal Symptoms, Constipation | NA | Status: RECRUITING